466 related articles for article (PubMed ID: 17295660)
1. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
McTaggart SJ; Atkinson K
Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.
Kode JA; Mukherjee S; Joglekar MV; Hardikar AA
Cytotherapy; 2009; 11(4):377-91. PubMed ID: 19568970
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory function of mesenchymal stem cells.
Uccelli A; Moretta L; Pistoia V
Eur J Immunol; 2006 Oct; 36(10):2566-73. PubMed ID: 17013987
[TBL] [Abstract][Full Text] [Related]
4. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
Arinzeh TL
Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of fetal and adult mesenchymal stem cells.
Le Blanc K
Cytotherapy; 2003; 5(6):485-9. PubMed ID: 14660044
[TBL] [Abstract][Full Text] [Related]
7. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of genetically modified mesenchymal stem cells.
Kumar S; Chanda D; Ponnazhagan S
Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
[TBL] [Abstract][Full Text] [Related]
9. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
Leal A; Ichim TE; Marleau AM; Lara F; Kaushal S; Riordan NH
Cell Immunol; 2008; 253(1-2):11-5. PubMed ID: 18627903
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model.
Cavaglieri RC; Martini D; Sogayar MC; Noronha IL
Transplant Proc; 2009 Apr; 41(3):947-51. PubMed ID: 19376395
[TBL] [Abstract][Full Text] [Related]
11. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
Giordano A; Galderisi U; Marino IR
J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
14. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Jones BJ; McTaggart SJ
Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
17. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury.
Semedo P; Palasio CG; Oliveira CD; Feitoza CQ; Gonçalves GM; Cenedeze MA; Wang PM; Teixeira VP; Reis MA; Pacheco-Silva A; Câmara NO
Int Immunopharmacol; 2009 Jun; 9(6):677-82. PubMed ID: 19146993
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury.
Semedo P; Wang PM; Andreucci TH; Cenedeze MA; Teixeira VP; Reis MA; Pacheco-Silva A; Câmara NO
Transplant Proc; 2007 Mar; 39(2):421-3. PubMed ID: 17362746
[TBL] [Abstract][Full Text] [Related]
19. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
